Bausch + Lomb Corporation announced the creation of Orphia, a new AI-powered digital health platform built on the belief that eyecare providers should spend less time managing disconnected tools and technologies and more time caring for patients. The platform is brand agnostic and designed to serve all eyecare providers, regardless of the products, devices, or treatments they choose to use, the company said in a press release. 

Orphia will operate under Digital Health Services, a newly created platform at Bausch + Lomb. The first application of the Orphia digital health platform focuses on pre-surgery cataract education, helping patients understand their condition and treatment options, identifying concerns, and preparing them before they meet with their surgeon. The company said the goal is to ensure patients arrive informed and ready, so conversations with their surgeon are more meaningful. 

To assist with the development of conversational patient engagement capability, Bausch + Lomb has engaged Hippocratic AI, a company that specializes in voice AI agents for health care and life sciences, with a proprietary LLM built on more than 200 million real patient interactions. 

Orphia is designed to integrate with the systems that practices already use, complementing existing workflows and creating actionable insights for clinical teams. Over time, Bausch + Lomb plans to expand the platform’s capabilities to support the full patient journey, from care coordination to practice workflow, reducing the operational burden that stands between physicians and their patients, the company said in the press release.